Closely monitoring international efforts aimed at combating climate change, Abdi İbrahim aims to become carbon neutral by 2030 and achieve net zero by 2050 through structured efforts to reduce its CO₂ emissions.

As decarbonization and the journey toward net-zero emissions become increasingly important along with the climate crisis, Abdi İbrahim executes a range of projects to curtail its carbon emissions, embracing clean technologies that facilitate the transition to a low-carbon economy and aiming for “net zero” emissions across its entire value chain.

Our carbon footprint, which we calculate annually, is verified by a third party organisation. You can access our carbon footprint data verified with limit assurance according to ISAE 3000 (Revised) Standard in our 2023 CDP Report.

‍Abdi İbrahim is accelerating its efforts towards energy efficiency and renewable electricity to achieve decarbonization and net zero emissions. Accordingly, Abdi İbrahim attaches great importance to the effective use of energy resources and ensures continuous development in this field through its Energy Board. Consisting of directors, managers, engineers and technicians, the Energy Board holds general evaluation meetings at least twice a year and has a sub-committee of 85 people. All technical personnel contribute to sub-working groups according to their areas of expertise.

Manufacturing pharmaceuticals with water of suitable properties to serve human health in the most efficient way, Abdi İbrahim takes great care to ensure water sustainability. The Company prioritizes its efforts to save water, which is essential for the future of the world. All necessary precautions are taken to save water at every stage of production at the Esenyurt Production Complex. At the facility, the wastewater is biologically enhanced with membrane bioreactor (MBR) technology, and performance is continuously monitored. With this initiative, the outlet water quality has been improved by 70 percent and reduced to well below discharge standards.

Abdi İbrahim focuses on the efficient utilization of water through the diligent efforts of its employees and automated control systems. The facility uses both photocell and filter taps in the sinks and in the washing cabins of the production areas. There are irrigation systems in place to ensure that water flows only when needed, as well as production equipment with automatic washing features. Projects for saving water are also utilised at the Abdi İbrahim Tower. Using water filter cartridges, the facility's water consumption was reduced by 71 tonnes per month in 2021 thanks to the controlled use of tap water.

Taking a major step towards healing the world and the future through sustainable water management, Abdi İbrahim was the first company in the Turkish pharmaceutical industry to sign the CEO Water Mandate, a United Nations Global Compact initiative. Accordingly, the Company will support water conservation policies that are implemented simultaneously worldwide in line with their commitments.

In accordance with its Waste Management Procedure, Abdi İbrahim separates all waste generated during its activities at the source. The Company also fulfils all its obligations in accordance with the Environmental Legislation. Abdi İbrahim works with companies licensed by the Ministry of Environment, Urbanization and Climate Change for the recovery and disposal of waste. With both the Esenyurt Production Complex and the Abdi İbrahim Tower recognized with the Zero Waste Certificate by the Ministry of Environment, Urbanization and Climate Change, Abdi İbrahim contributes to recycling by separating waste at the source.

With the aim to reduce of waste as part of its circular economy activities, Abdi İbrahim is working on major projects such as reducing the consumption of product packaging, using 100 percent recycled paper in the production of package inserts and boxes, making blister packs and other packaging which have biodegradable content, collecting medical waste and recycling packaging into the economy.

Reduce

In the “reduce” phase, the goal was to reduce the size of blister packs that are widely used in Abdi İbrahim's production activities with the Smart Software project, which is based on artificial intelligence and optimization techniques. In a groundbreaking collaboration with the TOBB University of Economics and Technology (TOBB ETÜ), the world pharmaceutical industry has, for the first time, developed an algorithm that centers on the design phase, aimed exclusively at reducing carbon emissions. Commencing with 26 licensed Abdi İbrahim products, the "reduce" phase has led to reductions in the use of aluminium, PVC and paper—carbon-intensive inputs in pharmaceutical production. This initiative resulted in the saving of 179 tonnes of packaging materials, energy savings equivalent to the annual electricity consumption of 150 households, the prevention of 90 kg of production waste and the recovery of 6 weeks of free capacity. This has also led to a 2,300-unit reduction in annual pallet circulation and annual material savings worth EUR 1 million. In the subsequent phases, the plan is to expand the scope of the project, which will include the reduction of packaging for additional products.

Switch

In the "switch" phase, the objective is to switch shrink-wrapped packaging with biodegradable plastic, known for producing significantly fewer carbon emissions than PVC. The initial products to undergo this “switch” phase will be the plastic tubes and caps used in Abdi İbrahim's consumer health products. The first prototype tubes were produced in the framework of a university-industry R&D collaboration with Sabancı University Nanotechnology Research and Application Center (SUNUM). With the application of biodegradable materials, the goal is to achieve a 75 percent reduction in carbon emissions per product which are caused packaging raw material compared to the current version. Pending successful stability studies, the next phase will involve switching all PVC-based blister packaging with biodegradable materials.

Collect

In the "collection" phase, the objective is to initially collect the consumer health product packaging that has been switched with biodegradable materials, subsequently sending them to biogas facilities for anaerobic degradation. This process will facilitate the complete biodegradation of the tubes, yielding compost and biogas. The resulting compost will be made available to farmers, supporting the local economy. Simultaneously, this will support sustainable energy resources by enhancing biogas production.